https://www.investors.com/news/technology/vertex-pharmaceuticals-alpine-stock-takeover/

I can't get my mind wrapped around Zenith lack of Market Enterprice valuation of say .80 cents a share when Alpine Immune which is a mid stage clinical trial biotech gets bought for $4.9 Billion when Zenith has several clinical trials in several indications and we can't even get a royalty deal  or larger BP partnership deal .  ITs absolutely unreal why DM won't step aside and bring in a seasoned Biotech executive  to get a deal done.  

DM prove me wrong and  get a deal done ASAP